Showing 1060 – 1070 of 1158 results
-
Tradeweb Markets Inc Initiation
William Blair initiated research coverage of Tradeweb Markets Inc. (TW $102.40), a leading operator of electronic marketplaces for rates, credit, equities, and money markets, with a focus on fixed income.
-
LENZ Therapeutics Inc Initiation
William Blair initiated research coverage of LENZ Therapeutics, Inc. (LENZ $21.73), a late-stage clinical company developing ophthalmic pharmaceutical products to improve vision.
-
Cullinan Oncology Inc Initiation
William Blair initiated research coverage of Cullinan Oncology, Inc. (CGEM $17.37), a company focused on advancing modality-agnostic targeted therapies for cancer, with a broad pipeline encompassing small molecules and multifunctional therapies across a diverse range of oncologic targets.
-
Kenvue Inc Initiation
William Blair initiated research coverage of Kenvue Inc. (KVUE $20.82), a global leader at the intersection of consumer goods and healthcare.
-
Ingram Micro Holding Corporation Initiation
William Blair initiated research coverage of Ingram Micro Holding Corporation (INGM $23.47), a leading IT distributor with operations in over 50 countries and more than 161,000 customers.
-
CARGO Therapeutics Inc Initiation
William Blair initiated research coverage of Cargo Therapeutics, Inc. (CRGX $16.23), a clinical-stage biotech company focused on developing next-generation CAR-T therapies for the treatment of cancer.
-
Modine Manufacturing Company Initiation
William Blair initiated research coverage of Modine Manufacturing Company (MOD $99.50). Modine provides thermal management solutions across two segments: climate solutions and performance technologies.
-
Kinnate Biopharma Inc Initiation
William Blair initiated research coverage of Kinnate Biopharma Inc. (KNTE $22.64), a development-stage biopharmaceutical company focused on discovering and developing small molecule kinase inhibitors for genetically defined cancers.
-
Tempus AI, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Tempus AI, Inc. (TEM $30.88), a company that provides precision medicine solutions for patients and uses its data platform to offer insights for researchers and pharma companies.
-
Inari Medical Inc Initiation
William Blair initiated research coverage of Inari Medical, Inc. (NARI $54.73), a medical device company that develops interventional products for patients suffering from venous diseases.